People: CytRx Corp (CYTR.W)

CYTR.W on CBOE When Trading NASDAQ Global Select Market

2.30USD
23 May 2013
Price Change (% chg)

$-0.12 (-4.96%)
Prev Close
$2.42
Open
$2.30
Day's High
$2.30
Day's Low
$2.30
Volume
100
Avg. Vol
63
52-wk High
$5.39
52-wk Low
$1.62

Search Stocks

Wieland, Douglas 

Brief Biography

Dr. Douglas Scott Wieland, Ph.D., is Senior Vice President - Drug Development of CytRx Corporation. He joined CytRx in 2005 as the Vice President, Clinical and Regulatory Affairs and was promoted to the position of Senior Vice President, Drug Development in December 2008. Prior to that, he served in senior level positions in the areas of Drug Development, Clinical and Regulatory Affairs at various biotech firms. He spent five years at NeoTherapeutics, Inc. serving as the Director of Product Development and was later promoted to Vice President of Product Development. From 1990 to 1997, he served as Director of Regulatory Affairs at CoCensys, Inc. Dr. Wieland has a Ph.D. in Biopsychology and an M.A. in Psychology from the University of Arizona. He has an MBA from Webster University. Dr. Wieland received his B.S. in Physiological Psychology from the University of California, Santa Barbara.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
405,000 -- 131,000 536,000

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Max Link

--

Steven Kriegsman

1,518,700

Marvin Selter

--

John Caloz

546,000

Daniel Levitt

786,900

Douglas Wieland

536,000
As Of 30 Dec 2012
Search Stocks